Milind B. Suraokar

发表

DeMix: deconvolution for mixed cancer transcriptomes using raw measured data

Wenyi Wang, Ying Yuan, Jaeil Ahn, 2013, Bioinform..

Frequent Coamplification and Cooperation between C-MYC and PVT1 Oncogenes Promote Malignant Pleural Mesothelioma

David C. Rice, Ignacio I. Wistuba, Barbara Mino, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

VEGF/VEGFR-2 Upregulates EZH2 Expression in Lung Adenocarcinoma Cells and EZH2 Depletion Enhances the Response to Platinum-Based and VEGFR-2–Targeted Therapy

Milind B. Suraokar, K. Coombes, Jing Wang, 2014, Clinical Cancer Research.

Immunohistochemical overexpression of platelet-derived growth factor receptor-beta (PDGFR-β) is associated with PDGFRB gene copy number gain in sarcomatoid non-small-cell lung cancer.

Milind B. Suraokar, W. Hong, I. Wistuba, 2011, Clinical lung cancer.

Metastasis is regulated via microRNA-200/ZEB1 axis control of tumor cell PD-L1 expression and intratumoral immunosuppression

Lixia Diao, F. Xiao-Feng Qin, Gordon Robertson, 2014, Nature Communications.

Glycogen Synthase Kinase-3β Is Involved in the Phosphorylation and Suppression of Androgen Receptor Activity*

Milind B. Suraokar, A. Sabichi, S. Lippman, 2004, Journal of Biological Chemistry.

Genetic mutation of p53 and suppression of the miR-17∼92 cluster are synthetic lethal in non-small cell lung cancer due to upregulation of vitamin D Signaling.

Alexander Pertsemlidis, Ignacio I Wistuba, John D Minna, 2015, Cancer research.

miR-337-3p and Its Targets STAT3 and RAP1A Modulate Taxane Sensitivity in Non-Small Cell Lung Cancers

John D. Minna, Alexander Pertsemlidis, Ignacio I. Wistuba, 2012, PloS one.

TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs

Milind B. Suraokar, I. Wistuba, C. Creighton, 2010, Nature.

The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network.

Milind B. Suraokar, I. Wistuba, C. Creighton, 2018, The Journal of clinical investigation.

Biology of Human Tumors VEGF / VEGFR-2 Upregulates EZH 2 Expression in Lung Adenocarcinoma Cells and EZH 2 Depletion Enhances the Response to Platinum-Based and VEGFR-2 – Targeted Therapy

Milind B. Suraokar, K. Coombes, Jing Wang, 2014 .

Expression pattern of FGFR2, Grb2 and Plcγ1 acts as a novel prognostic marker of recurrence recurrence-free survival in lung adenocarcinoma.

Milind B. Suraokar, Xin Hu, I. Wistuba, 2015, American journal of cancer research.

Oleandrin-mediated inhibition of human tumor cell proliferation: Importance of Na,K-ATPase α subunits as drug targets

Milind B. Suraokar, M. Suraokar, R. Newman, 2008, Molecular Cancer Therapeutics.

Radiation-Enhanced Lung Cancer Progression in a Transgenic Mouse Model of Lung Cancer Is Predictive of Outcomes in Human Lung and Breast Cancer

Milind B. Suraokar, J. Minna, I. Wistuba, 2014, Clinical Cancer Research.

Imaging , Diagnosis , Prognosis Radiation-Enhanced Lung Cancer Progression in a Transgenic Mouse Model of Lung Cancer Is Predictive of Outcomes in Human Lung and Breast Cancer

Milind B. Suraokar, J. Minna, I. Wistuba, 2014 .

High Expression of Folate Receptor Alpha in Lung Cancer Correlates with Adenocarcinoma Histology and Mutation

Milind B. Suraokar, J. Lee, W. Franklin, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

BSTA Promotes mTORC2-Mediated Phosphorylation of Akt1 to Suppress Expression of FoxC2 and Stimulate Adipocyte Differentiation

Milind B. Suraokar, G. Mills, Yiling Lu, 2013, Science Signaling.

Nrf2 and Keap1 Abnormalities in Non–Small Cell Lung Carcinoma and Association with Clinicopathologic Features

Stephen G Swisher, B Nebiyou Bekele, Shyam Biswal, 2010, Clinical Cancer Research.

A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non–Small Cell Lung Cancer Patients

Milind B. Suraokar, J. Minna, I. Wistuba, 2013, Clinical Cancer Research.

Small Cell Lung Cancer Patients − Chemotherapy in Non A 12-Gene Set Predicts Survival Benefits from Adjuvant

Milind B. Suraokar, J. Minna, I. Wistuba, 2013 .

Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations

Milind B. Suraokar, J. Martinez-Climent, I. Wistuba, 2015, BMC Genomics.

Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications.

Milind B. Suraokar, I. Wistuba, C. Behrens, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors.

Milind B. Suraokar, K. Coombes, B. Garcia, 2017, Cell reports.